ClinicalTrials.gov
ClinicalTrials.gov Menu

Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00239109
Recruitment Status : Completed
First Posted : October 14, 2005
Last Update Posted : March 18, 2008
Sponsor:
Information provided by:
Pfizer

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : February 2007